Try our Advanced Search for more refined results
Purdue Pharma L.P.
Case Number:
7:19-bk-23649
Court:
Nature of Suit:
Firms
- Brown & Connery
- Tarter Krinsky
- Teitelbaum Law Group
- Duane Morris
- Hagens Berman
- Simmons Hanly
- Caplin & Drysdale
- Motley Rice
- Debevoise & Plimpton
- Bielli & Klauder
- Godfrey & Kahn
- Himes Petrarca
- Manatt Phelps
- Wachtell Lipton
- Hurwitz Fine
- Morris Nichols
- Gilbert LLP
- BatesCarey
- Lowe Stein
- Arnold & Porter
- Archer & Greiner
- Katsky Korins
- Brown Rudnick
- Gage Spencer & Fleming
- Pashman Stein
- Hogan Lovells
- Katten Muchin
- Morrison & Foerster
- Doshi Legal Group
- Willkie Farr
- Buchalter LLP
- FBT Gibbons
- Terrell Hogan
- Troutman
- Goodwin Procter
- Davis Polk
- Foley & Lardner
- Pillsbury Winthrop
- ArentFox Schiff
- Phillips Lytle
- Dentons
- HSF Kramer
- Crowell & Moring
- Morgan Lewis
- Reed Smith
- McDermott Will & Schulte
- Gertz & Rosen
- Consovoy McCarthy
- Porteous Hainkel
- Rothstein Mandell
- Ice Miller
- Jones Day
- Porter Hedges
- Kirkland & Ellis
- Bentley & Bruning
- ASK LLP
- Joseph Hage
- Doster Ullom
- Marino Tortorella
- White & Case
- Boies Schiller
- Spangenberg Shibley
- Cuneo Gilbert
- MoloLamken
- Mintz Levin
- WestLoop Law
- Miller Nash LLP
- Cronin Fried
- Loeb & Loeb
- Diamond McCarthy
- Slevin & Hart
- Plevin & Turner
- Schenck Price
- Bialson Bergen
- Martin S. Rapaport
- Skadden Arps
- Akerman LLP
- Fox Swibel
- Lerner Arnold
- Burke Warren
- Shook Hardy
- Sherrard Roe
- Taft Stettinius
- Sahn Ward
- Cleary Gottlieb
- Simpson Thacher & Bartlett
- Napoli Shkolnik
- D. Miller & Associates
- McGrail & Bensinger
- Marcus & Shapira
- Quinn Emanuel
- Pachulski Stang
- King & Spalding
- UB Greensfelder
- Wilk Auslander
- Stevens & Lee
- Faegre Drinker
- Shafferman & Feldman
- Squire Patton
- Blitman & King
- Hughes Socol
- Robins Kaplan
- WilmerHale
- Blank Rome
- Keller Rohrback
- Kobre & Kim
- Ballard Spahr
- O'Melveny & Myers
- Keller Postman
- Webb Law Firm
- Kleinberg Kaplan
- Clifford Law Offices
- Barack Ferrazzano
- Stutzman Bromberg
- Levenfeld Pearlstein
- Seyfarth Shaw
- MacElree Harvey
- Klehr Harrison
- Pullman & Comley
- Mehri & Skalet
- Tate Law Group LLC
- Lowey Dannenberg
- Williams Mullen
- Waldrep Wall
- Barclay Damon
- Dechert LLP
- Ifrah Law
- Seward & Kissel
- Calfee Halter
- White Coleman & Associates
- Miller Shah
- Susman Godfrey
- O'Brien Belland
- Binder & Schwartz
- Alston & Bird
- Akin Gump
- Carter Ledyard
- Shipman & Goodwin
- McElroy Deutsch
- Henrichsen Law Group
- Jenner & Block
- Haug Partners
- Hobbs Straus
- Latham & Watkins
- Mayer Brown
- Milbank LLP
Companies
- Teamsters Local 456
- Henry Schein Inc.
- Cencora Inc.
- Bristol-Myers Squibb Co.
- Hikma Pharmaceuticals PLC
- Giant Eagle Inc.
- McKesson Corp.
- BDO LLP
- Otis Worldwide Corp.
- Johnson & Johnson
- Liberty Mutual Insurance Group
- FTI Consulting Inc.
- Kodiak Area Native Association
- Ranbaxy
- PRA Health Sciences Inc.
- Ascent Pharmaceuticals Inc.
- Blue Cross Blue Shield Association
- Aleutian Pribilof Islands Association Inc.
- KVK Tech Inc.
- Collegium Pharmaceutical Inc.
- Noramco Inc.
- Endo International PLC
- Impax Laboratories, Inc.
- Omnicare Inc.
- Bausch Health Cos. Inc.
- Province LLC
- Sandoz International GmbH
- Avrio Health LP
- Nardello & Co. LLC
- DuPont de Nemours Inc.
- Hain Capital Group LLC
- United Parcel Service Inc.
- Express Scripts Holding Co.
- CVS Health Corp.
- Ironshore Inc.
- Amneal Pharmaceuticals Inc.
- Sun Pharmaceutical Industries Ltd.
- Loblaw Cos.
- Tucson Medical Center
- TR Capital Management LLC
- Viatris Inc.
- The Cigna Group
- Alaska Native Tribal Health Consortium
- Anda Inc.
- Walmart Inc.
- AXA XL Ltd.
- Allergan PLC
- BDO USA LLP
- Rubris Inc.
- AlixPartners LLP
- Purdue Pharma LP
- United Food & Commercial Workers International Union
- ASM Capital LP
- SAP AG
- Apria Healthcare Group
- Cardinal Health Inc.
- Arcadia Consumer Healthcare
- International Union Of Operating Engineers
- Old Republic Insurance Co.
- Oracle Corp.
- Thermo Fisher Scientific Inc.
- Verita Global LLC
- Houlihan Lokey Inc.
- American Federation of Labor & Congress of Industrial Organizations
- Jefferies Financial Group Inc.
- Teva Pharmaceutical Industries Ltd.
Government Agencies
- Pension Benefit Guaranty Corp.
- Missouri Department of Revenue
- U.S. District Court for the District of Columbia
- Tennessee Attorney General's Office
- Pala Band of Mission Indians
- Seldovia Village Tribe
- Nez Perce Tribe
- Town of Ramapo, New York
- Jamestown S'Klallam Tribe
- St. Regis Mohawk Tribe
- State of Indiana
- City of Bayonne, New Jersey
- Washington State Department of Revenue
- Colorado Attorney General's Office
- Port Gamble S'Klallam Tribe
- Borough of Paramus, New Jersey
- State of Nevada
- Northwestern Band of the Shoshone Nation
- Town of Babylon, New York
- Town of Brookhaven, New York
- New York Department of Financial Services
- Town of Hempstead, New York
- Commonwealth of Massachusetts
- Hopi Tribe
- Suquamish Tribe
- Ohio Attorney General's Office
Sectors & Industries:
-
May 26, 2021
Purdue Statement Gives Creditors Enough Info, Judge Says
A New York bankruptcy judge gave a preliminary nod Wednesday to Purdue Pharma's Chapter 11 plan disclosures, but held off on an approval order after the drugmaker said it needed to clear up some disputes and add a few details to the statement.
-
May 24, 2021
Purdue's New Ch. 11 Plan Docs Detail Claims Trust Framework
Bankrupt drug manufacturer Purdue Pharma LP filed an amended Chapter 11 plan and supporting documents Monday in New York court that provide details on how $1.4 billion in distributions will be shared by different groups of claimants in the case.
-
May 20, 2021
Purdue Says It May Have To Push Back Ch. 11 Schedule
Drugmaker Purdue Pharma told a New York bankruptcy judge Thursday that it may not be able to keep to the schedule it set for its Chapter 11 case, saying it is hitting some "intractable" issues as it negotiates the terms of its restructuring.
-
May 12, 2021
Purdue's Ch. 11 Confirmation Hearing Set For August
A New York bankruptcy judge on Wednesday approved a motion setting an August date for Purdue Pharma's Chapter 11 plan confirmation hearing, assuming the drugmaker's plan disclosure statement is approved next week.
-
May 07, 2021
Purdue Asks For Another Month's Hold On Opioid Suits
Purdue Pharma is asking a New York bankruptcy judge for another 27-day extension of an injunction freezing opioid suits against the company and its owners, saying it needs more time to ensure it gets court approval for its Chapter 11 plan disclosures.
-
April 27, 2021
Newborn Opioid Victim Group Says Purdue Docs Lack Info
A group representing the interests of victims of neonatal abstinence syndrome in the bankruptcy case of opioid maker Purdue Pharma told a New York judge late Monday that the debtor's Chapter 11 plan documents don't provide enough information about their treatment.
-
April 08, 2021
Purdue Wants Another Month's Reprieve From Opioid Suits
Purdue Pharma has asked a New York bankruptcy judge for another month of relief from lawsuits over its opioid sales, saying negotiations on the final form of its Chapter 11 plan are at a "critical stage."
-
April 06, 2021
Purdue Judge Wary Of Changing Reasons For Ch. 11 Probe
A New York bankruptcy judge has asked a committee representing children allegedly injured by Purdue Pharma-made opioids to clarify why they are seeking a probe into OxyContin toxicology studies, saying its reasons have shifted since they first asked.
-
March 24, 2021
Purdue, Sackler Opioid Suits Paused For Another Month
A New York bankruptcy judge on Wednesday granted Purdue Pharma and its former owners another month's relief from suits over Purdue's opioid sales, saying the continued pause will protect efforts to work out the details of the company's Chapter 11 plan.
-
March 22, 2021
States Say Time Has Come To Let Sackler Suits Proceed
A group of states asked a New York bankruptcy judge Friday to deny Purdue Pharma's latest request to extend the injunction pausing their suits against the Sackler family, saying allowing their claims to go forward will create a better Chapter 11 plan.